Catégorie
Dexamethasone sodium phosphate
Numéro CAS
Dexamethasone sodium phosphate STD-2392-39-4: IMP-A-50-02-2: IMP-C-NA: IMP-D-NA: IMP-E-NA: IMP-F-NA: IMP-G-37927-01-8
Formule moléculaire
Dexamethasone sodium phosphate STD-C22H28FNa2O8P: IMP-A-C22H29FO5: IMP-C-C22H30FO8P: IMP-D-C22H28FNa2O8P: IMP-E-C22H30FO8P: IMP-F-C22H30FO8P: IMP-G-C21H27FO5
Masse moléculaire
Dexamethasone sodium phosphate STD-516.40: IMP-A-392.47: IMP-C-472.44: IMP-D-516.41: IMP-E-472.4: IMP-F-472.45: IMP-G-378.43
Synonyme

Dexamethasone sodium phosphate STD-9-Fluoro-11beta,17-dihydroxy-16a-methyl-3,20-dioxopregna-1,4-dien-21-yl disodium phosphate; Dexamethasone 21-phosphate Disodium Salt (USP); disodium;[2-[(8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] phosphate

Dexamethasone sodium phosphate EP-Impurity-A-9-fluoro-11beta,17,21-trihydroxy-16a-methylpregna-1,4-diene-3,20-dione; (8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one; Dexamethasone (USP)

Dexamethasone sodium phosphate EP-Impurity-C-((1R,3R,4aS,4bS,10aS,10bR,11S,12aS)-10b-Fluoro-1,11-dihydroxy-3,10a,12a-trimethyl-2,8-dioxo-1,2,3,4,4a,4b,5,6,8,10a,10b,11,12,12a-tetradecahydrochrysen-1-yl)methyl dihydrogen phosphate; D-Homo B Derivative of Dexamethasone

Dexamethasone sodium phosphate EP-Impurity-D-Sodium ((1S,3R,4aS,4bS,10aS,10bR,11S,12aS)-10b-fluoro-1,11-dihydroxy-3,10a,12a-trimethyl-2,8-dioxo-1,2,3,4,4a,4b,5,6,8,10a,10b,11,12,12a-tetradecahydrochrysen-1-yl)methyl phosphate; 16(17)a-Homodexamethasone Sodium Phosphate (16α)

Dexamethasone sodium phosphate EP-Impurity-E-((2S,3R,4aS,4bS,10aS,10bR,11S,12aS)-10b-Fluoro-2,11-dihydroxy-3,10a,12a-trimethyl-1,8-dioxo-1,2,3,4,4a,4b,5,6,8,10a,10b,11,12,12a-tetradecahydrochrysen-2-yl)methyl dihydrogen phosphate

Dexamethasone sodium phosphate EP-Impurity-F-((3R,10aS,10bR,11S,12aS)-10b-fluoro-2,11-dihydroxy-3,10a,12a-trimethyl-1,8-dioxo-1,2,3,4,4a,4b,5,6,8,10a,10b,11,12,12a-tetradecahydrochrysen-2-yl)methyl dihydrogen phosphate

Dexamethasone sodium phosphate EP-Impurity-G-(8S,9R,10S,11S,13S,14S,16R,17R)-9-Fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthrene-17-carboxylic Acid; 9-Fluoro-11β,17-dihydroxy-16α-methyl-3-oxoandrosta-1,4-diene-17β-carboxylic Acid; Dexamethasone Acid; (8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carboxylic acid

slide.1
Purity:

Above - 95.0%

Technical Data:

We will provide complete documentation support for every Standard Material. All analytical reports such as ¹H NMR, ¹³C NMR, Mass, FT-IR, HPLC Purity/GC Purity/QNMR Purity, Water content by KF/ Loss on Drying/TGA (Thermo-gravimetric Analysis). Certificate of Analysis with potency report. Each Standard Material SER (Structure Elucidation Report) with NMR, Mass, IR spectral interpretation. This whole analytical document can be included in eCTD, ANDA, DMF submissions to regulatory agencies.

Dexamethasone sodium phosphate for peak identification CRS is a certified reference substance used in chromatographic analysis. It helps accurately identify the dexamethasone sodium phosphate peak, confirming retention time and peak purity in HPLC or similar methods. This ensures correct identification of the drug in pharmaceutical substances and formulations, supporting reliable analysis and compliance with pharmacopeial standards.